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R factor = 0.050; wR factor = 0.128; data-to-parameter ratio = 34.1.
In title compound, C7H8N2S, the ﬁve-membered rings are
twisted by a dihedral angle of 5.17 (10) . Two intermolecular
N—H   N and C—H   N hydrogen bonds to the same
acceptor N atom form seven-membered rings, producing
R2
1(7) ring motifs. These interactions link neighbouring
molecules into one-dimensional chains extended along the c
axis. The crystal structure is further stabilized by weak
intermolecular C—H     interactions.
Related literature
For reference geometrical data, see: Allen et al. (1987). For
details of hydrogen-bond motifs, see: Bernstein et al. (1995).
For a related structure and the synthesis, see, Kia et al. (2008);
Stibrany et al. (2004). For the applications of imidazoline
derivatives, see, for example: Blancafort (1978); Chan (1993);







a = 6.1321 (2) A ˚
b = 11.5663 (3) A ˚
c = 10.0098 (3) A ˚
  = 90.154 (1) 
V = 709.95 (4) A ˚ 3
Z =4
Mo K  radiation
  = 0.37 mm
 1
T = 100.0 (1) K
0.54   0.28   0.22 mm
Data collection




Tmin = 0.825, Tmax = 0.922
27675 measured reﬂections
3100 independent reﬂections












 max = 0.62 e A ˚  3
 min =  0.39 e A ˚  3
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
N1—H1N1   N2
i 0.75 2.23 2.977 (2) 171
C3—H3A   N2
i 0.95 2.60 3.482 (2) 155
C6—H6A   Cg1
ii 0.99 2.89 3.539 (2) 124
C6—H6B   Cg1
iii 0.99 2.83 3.691 (2) 146
Symmetry codes: (i) x; y þ 1
2;z þ 1
2; (ii)  x;y þ 1
2; z þ 3
2; (iii) x   1;y;z. Cg1i st h e
centroid of the S1/C1–C4 (thiophen) ring.
Data collection: APEX2 (Bruker, 2005); cell reﬁnement: SAINT
(Bruker, 2005); data reduction: SAINT; program(s) used to solve
structure: SHELXTL (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXTL; molecular graphics: SHELXTL; software used
to prepare material for publication: SHELXTL and PLATON (Spek,
2003).
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Supplementary data and ﬁgures for this paper are available from the
IUCr electronic archives (Reference: AT2706).
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Key indicators: single-crystal X-ray study; T = 100 K; mean  (C–C) = 0.001 A ˚;
R factor = 0.027; wR factor = 0.080; data-to-parameter ratio = 32.3.
Consideration of a previous unrecognized twinning of the
original investigated crystal of the title compound [Kia et al.
(2009). Acta Cryst. E65, o301] led to improved reliability
factors and to a slightly higher precision for all geometric
parameters. The crystal under investigation was twinned by
pseudo-merohedry with [100, 010, 001] as the twin matrix and
a reﬁned twin domain fraction of 0.9610 (5):0.0390 (5). The






a = 6.1321 (2) A ˚
b = 11.5663 (3) A ˚
c = 10.0098 (3) A ˚
  = 90.154 (1) 
V = 709.95 (4) A ˚ 3
Z =4
Mo K  radiation
  = 0.37 mm
 1
T = 100 K
0.54   0.28   0.22 mm
Data collection




Tmin = 0.825, Tmax = 0.922
28316 measured reﬂections
3100 independent reﬂections











H atoms treated by a mixture of
independent and constrained
reﬁnement
 max = 0.52 e A ˚  3
 min =  0.24 e A ˚  3
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
N1—H1   N2
i 0.857 (16) 2.130 (16) 2.9803 (10) 171.5 (16)
C3—H3A   N2
i 0.95 2.59 3.4815 (11) 156
Symmetry code: (i) x; y þ 1
2;z þ 1
2.
Data collection: APEX2 (Bruker, 2005); cell reﬁnement: SAINT
(Bruker, 2005); data reduction: SAINT; program(s) used to solve
structure: SHELXTL (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXTL (Sheldrick, 2008); molecular graphics:
SHELXTL (Sheldrick, 2008); software used to prepare material for
publication: SHELXTL (Sheldrick, 2008) and PLATON (Spek,
2009).
Supplementary data and ﬁgures for this paper are available from the
IUCr electronic archives (Reference: WM2233).
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